Making clinical decisions when the stakes are high and the evidence unclear.
Hu
Wendy
W
School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW 2052, Australia. wendy.hu@unsw.edu.au
Kemp
Andrew
A
Kerridge
Ian
I
D000707:Anaphylaxis / Q000191:economics / Q000517:prevention & control; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis / Q000941:ethics; D003657:Decision Making / Q000941:ethics*; D004837:Epinephrine / Q000008:administration & dosage* / Q000191:economics; D004992:Ethics, Medical; D006801:Humans; D007267:Injections / Q000941:ethics; D021183:Peanut Hypersensitivity / Q000517:prevention & control*; D011364:Professional Practice / Q000941:ethics; D018570:Risk Assessment / Q000941:ethics; D012307:Risk Factors
D001993:Bronchodilator Agents; D004837:Epinephrine